The global AI in genomics market was valued at USD 879.29 Million in 2025, fueled by the rising emphasis on personalized medicine and advancements in AI-driven genomics solutions across the globe. The market is anticipated to grow at a CAGR of 32.40% during the forecast period of 2026-2035, with the values likely to reach USD 14554.99 Million by 2035.
Base Year
Historical Period
Forecast Period
The growing incorporation of AI in genomics for drug development, gene modification, and diagnostic purposes is fueling market growth.
Collaborations between technology leaders and genomics firms are becoming common, aimed at enhancing AI applications in genomic studies, and promoting creative methods in personalized medicine. This is one of the major market trends, poised to impact market value positively in the forecast period.
North America dominates the market because of its robust healthcare infrastructure and significant AI research investment, whereas the Asia Pacific region is witnessing rapid growth.
Artificial intelligence in genomics is transforming healthcare by analyzing large genomic datasets to expedite discoveries, lower expenses, and enhance precision medicine. Major factors involve AI's influence on the efficiency of drug discovery and improved clinical processes. Trends such as the integration of AI in genome sequencing and sophisticated diagnostics are increasing demand, setting the AI in genomics industry up for strong market expansion as worldwide dependence on AI-powered solutions escalates.
Rising Applications in Drug Discovery and Development Drives Market Growth
AI is increasingly utilized in the drug discovery process because it can optimize research, lower development expenses, and decrease timelines. Through the analysis of genomic information, AI detects possible drug targets and streamlines the development process, greatly aiding the expansion of the AI in genomics market by improving efficiency and accelerating breakthroughs in personalized medicine.
Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Component
Market Breakup by Functionality
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on End User Set to Witness Substantial Growth
Based on end users, the market is divided into pharmaceutical and biotech companies, healthcare providers, research and academic institutes, and others. Among these, the pharmaceutical and biotech companies are expected to dominate the market. The market share can be attributed to an increase in combining AI and machine learning for managing clinical data, predicting diseases, and identifying biomarkers, thereby improving the efficiency of drug development. These innovations facilitate easy, more affordable research, addressing the growing need for AI in genomics and fostering its overall growth.
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America, with a strong healthcare system and leading healthcare companies, is projected to hold a substantial market share.
In the forecast period, the Asia Pacific region is expected to witness significant expansion. This can be attributed to heightened spending aimed at enhancing healthcare facilities and addressing varied patient needs. Due to the availability of skilled healthcare professionals, cost-effective treatments, and tailored care, nations such as India and South Korea are witnessing a rise in medical tourism.
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Founded in 1911, it has its corporate headquarters in New York, USA. IBM is a multinational corporation in engineering technology and consulting. In the genomics sector, IBM Watson Health has collaborated with Illumina to impose standards and provide easier interpretation of genomic data.
Founded in 1975, it has its corporate headquarters in Redmond, Washington. Microsoft is a leader in software and cloud computing services worldwide. The company uses its Microsoft Genomics service, providing open-source and open-standard-based solutions on the Azure platform to allow genomic analysis and speed precision health initiatives.
It was incorporated in 1956 with a corporate headquarters in Waltham, Massachusetts. The company supplies analytical instruments, laboratory equipment, and services to the genomics field, supporting research and clinical applications.
Founded in 1998 and headquartered in California, Illumina is a global leader in DNA sequencing and array-based technologies. The company is focused on innovation in genomics, serving customers within research, clinical, and applied markets.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include NVIDIA Corporation, DEEP GENOMICS, Data4Cure, Inc., Freenome Holdings, Inc., SOPHiA GENETICS, and BenevolentAI.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Component |
|
| Breakup by Functionality |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share